Article info
PDFOriginal article
Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2)
- Correspondence to Dr Mohamed Tarek M Shata, Viral Immunology Laboratory, Department of Internal Medicine, Division of Digestive Diseases, University of Cincinnati Medical Center, 231 Albert B. Sabin Way, MSB 6360, Cincinnati, OH 45267-0595, USA; mohamed.shata{at}uc.edu
Citation
Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2)
Publication history
- Received February 26, 2013
- Revised May 28, 2013
- Accepted June 13, 2013
- First published August 12, 2013.
Online issue publication
August 11, 2020
Article Versions
- Previous version (11 August 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions